Mutant Core

突变核心

• 批准号: 7727801
• 负责人: EDWARD G. SHESELY
• 金额: $ 32.73万
• 依托单位: HENRY FORD HEALTH SYSTEM
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7727801
• 关键词: AGTR2 gene; Angiotensin Receptor; Animals; Blood Pressure; Bradykinin B2 Receptor; Breeding; Budgets; CC chemokine receptor 2; Cardiac; Cardiac Myocytes; Complementary DNA; Core Facility; Doctor of Medicine; Doxycycline; Galectin 3; Gene Targeting; Genes; Genotype; Human; Investigation; Knock-out; Knockout Mice; Mouse Strains; Mus; Muscle Cells; Myosin Heavy Chains; Numbers; Protein Overexpression; Renal function; Research; Research Personnel; Response Elements; System; Tetracycline; Tetracycline Control; Tetracyclines; Tissue Kallikrein; Tissues; Transgenes; Transgenic Mice; Transgenic Organisms; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors; Vascular Smooth Muscle; Ventricular; diphtheria toxin receptor; human CREB1 protein; human TNF protein; human WFDC2 protein; knockout gene; macrophage; mutant; programs; promoter; prostaglandin E synthase-1; prostaglandin EP4 receptor; receptor expression